Pharmaceutics International, Inc. (Pii) Announces Expansion Of Commercial Capabilities

HUNT VALLEY, Md., March 10, 2015 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, MD, has announced the expansion of its commercial packaging capabilities. The expansion of more than 18,000 sq. ft. of converted warehouse space will be at the company's Golden West facility. The new cGMP area will include three new high speed automated bottling and powder filling lines and four blister packaging production suites, with dedicated air handling. The completion, planned for June 2015, is a strategic decision in preparation for future commercial production of over 40 products pending FDA approval. Steve King, Pii's Senior Vice President, noted, "The increased capacity and capabilities will support Pii's future growth and meet the growing needs of our existing and future commercial clients."

About Pharmaceutics International, Inc.

Pii is a privately held CDMO providing dosage form development and GMP manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley, Maryland USA with European facilities in the UK, services include pre-formulation testing, formulation development, clinical and commercial GMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, clinical trial kit building and distribution, analytical and QP services. Pii's facilities include manufacturing and containment suites, automated packaging lines and a wide selection of equipment. For more information, please visit www.pharm-int.com.

Contact:
Steve King, Senior Vice President
Pharmaceutics International, Inc.
10819 Gilroy Road
Hunt Valley, MD 21031
Phone: (410) 584-0001
Email: [email protected]

Logo - http://photos.prnewswire.com/prnh/20150310/180806LOGO

SOURCE Pharmaceutics International, Inc.

 

RELATED LINKS
http://www.pharm-int.com
More by this Source

Pharmaceutics International, Inc. (Pii) Provides Clinical Packaging And Distribution Services
Feb 05, 2015, 15:22 ET
View all news by Pharmaceutics International, Inc.
Journalists and Bloggers

 

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.